ACH BINDING PROTEIN
ACHBP
ACHBP
ACHBP
ACHBP DISPLAY
AXOPATCH
B AMPLIFIER
B MAX VALUE
BACKGROUND SEQUENCE HOMOLOGY
BECKMAN JA20 ROTOR
CA
CA
CPBG
CPBG
CPBG
CT
CHANGE MUTAGENESIS KIT
CHIRARA
D206
DMEM CULTURE MEDIUM
DMEM MEDIUM
DMEM MEDIUM
DMEM MEDIUM
DESENSITIZATION KINETICS
DETERMINATION
E LOOP REGION
E106
E106
EC
EC
EC
EC
F107
F107
FETAL           BOVINE SERUM
FETAL           BOVINE SERUM
FETAL           BOVINE SERUM
G147
G147
GABA
GABA
GABA
GRAPHPAD PRISM
HOMOLOGOUS RESIDUE
IDENTIFICATION
IDENTIFICATION
LIGAND SPECIFICITY IDENTIFICATION
K D VALUE
K153
LGIC RECEPTOR
LGIC SUBUNIT
LARGE CHANGE
LARGE DECREASE
LERISETRON
LERISETRON
LERISETRON INHIBITION
LITTLE CHANGE
M1 REGION
MUTAGENESIS KIT
MUTANT RECEPTOR
NY
ORALE
P154
PHOSPHATE BUFFERED SALINE
PHOSPHATE BUFFERED SALINE
PHOSPHATE BUFFERED SALINE
PHOSPHATE BUFFERED SALINE
PREVIOUS STUDY
PROMEGA
QIAGEN
R AGONIST
R AGONIST
R ANTAGONIST
R ANTAGONIST
R LIGAND
R LIGAND
R LIGAND
R LIGAND
R LIGAND
R LIGAND
R LIGAND
R. SEQUENCE HOMOLOGY
R104
R91
RECENT X-RAY
CRYSTALLOGRAPHIC DATA RECENT X-RAY
REPRESENTATIVE MEMBER
SAN DIEGO CA
SIMILAR SELECTIVE EFFECT
STRATAGENE
STRUCTURE-FUNCTION STUDY
SUBSTITUTION
SUBUNIT
SUPERFECT REAGENT
SUPERFECT TRANSFECTION REAGENT
SUPERFECT REAGENT
T142
TRANSFECTED CELL
TRANSFECTION
TUBOCURARINE INHIBITION
W143
W183
W183
W183
W183
W89
W89
W89
W89
Y140
Y140
Y140
Y140
Y140
Y140
Y140
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y152
Y152
Y152
Y152
Y152
Y152
Y152
Y152
Y152
Y152
ABILITY
ABILITY
ABILITY
ABILITY
ACETYLCHOLINE
ACETYLCHOLINE BINDING SITE
ACID/FUNCTIONAL GROUP INTERACTION
ADDITION
ADDITION
AFFINITY
AFFINITY
AFFINITY
AFFINITY
AFFINITY
AFFINITY
AFFINITY
AFFINITY
COMPOUND AFFINITY
AFFINITY LABELING
AFFINITY LABELING
AGONIST
AGONIST
AGONIST
AGONIST FLUMAZENIL
AGONIST APPLICATION
AGONIST BINDING
AGONIST BINDING DOMAIN
AGONIST RESPONSE
AGONIST
AGONIST
AGONIST
AGONIST
AGONIST
ALANINE
ALANINE MUTATION
ALANINE MUTATION
ALANINE MUTATION
ALANINE MUTATION
ALANINE MUTATION
ALANINE MUTATION
ALTERED RESPONSE KINETICS
ANTIPARALLEL Β-SHEET
CDNA
CATION-Π INTERACTION
CHLOROPHENYLBIGUANIDE
COMMERCIAL DNA SEQUENCING
COMPETITIVE ANTAGONIST
COMPLEMENTARY FACE
RECEPTOR SUBUNIT COMPLEMENTARY FACE
COMPLIMENTARY SIDE
COMPOUND
COMPOUND
COMPOUND
CONCENTRATION
CONCENTRATION RESPONSE CURVE
CONCENTRATION
CONCENTRATION
CONFORMATION
RECEPTOR CONFORMATION
CONFORMATIONAL CHANGE
CONFORMATIONAL CHANGE
CONSERVED GLYCINE RESIDUE
CONTINUOUS EXTRACELLULAR SOLUTION FLOW
CRITICAL GLYCINE RESIDUE
CRITICAL STEP
CRYSTALLOGRAPHIC DATA
CYSTEINE SUBSTITUTION
DESENSITIZATION
DESENSITIZATION
DESENSITIZATION
DESTABILIZATION
DETERMINATION
DIRECTED MUTAGENESI
ENDOGENOUS AGONIST
ENERGY
ESSENTIAL LOOP
EXAMPLE CONSTRUCTION
EXTRACELLULAR SOLUTION
EXTRACELLULAR SOLUTION FLOW RATE
FUNCTIONAL CHANGE
FUNCTIONAL CHANNEL
FUNCTIONAL GROUP
FUNCTIONAL GROUP
FUNCTIONAL GROUP
FUNCTIONAL GROUP
GLYCINE
GLYCINE
GLYCINE
GLYCINE
GLYCINE
GLYCINE HOMOLOGOUS
GLYCINE RECEPTOR
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON BINDING
GRANISETRON BINDING
GRANISETRON BINDING
GRANISETRON BINDING
HOLDING POTENTIAL
HOMOGENIZED
HOMOLOGOUS
HOMOLOGOUS ACHBP
HOMOLOGOUS REGION
HOMOLOGOUS REGION
HOMOLOGOUS RESIDUE
HOMOLOGOUS RESIDUE
HOMOLOGOUS SEQUENCE
HOMOMERIC
HOMOMERIC RECEPTOR
HYBRID
IDENTIFICATION
INCLUDING GABA
INCLUDING W183
INCREASED K D
INDIVIDUAL ALANINE MUTATION
INDIVIDUAL AMINO ACID
INDIVIDUAL AMINO ACID
INDIVIDUAL BINDING SITE LOOP
INDIVIDUAL MUTATION
INTERACTION
INTERACTION
INTERACTION
INTERACTION
INTERACTION
INTERACTION
INTERACTION
INTERVENING RESIDUE
INTRODUCTION
INVESTIGATION
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON BINDING
LIGAND
LIGAND
LIGAND
LIGAND
LIGAND
LIGAND
LIGAND BINDING DOMAIN
LIGAND BINDING SITE
LIGAND SPECIFICITY
LIGAND SPECIFICITY
LIGAND/RECEPTOR INTERACTION
LIGAND
LIGAND
LIGAND
LIGAND
LIGAND
LIGAND
LIGAND
LIGAND
M CPBG
M CPBG
M CPBG
M CPBG
M CPBG
M CPBG
M CPBG
M CPBG
M CPBG
MAXIMAL ACTIVATION
MIN
MIXTURE INCUBATED
ML PB
ML ICE
ML/MIN
MOLECULAR BASIS
MOLECULAR RULER
MOLECULE
MOLECULE
MOLECULE LERISETRON
M
MUTAGENESI
MUTAGENESIS STUDY
MUTAGENESIS STUDY
MUTANT
MUTANT
MUTANT RECEPTOR
MUTANT RECEPTOR
MUTANT RECEPTOR
MUTANT RECEPTOR
MUTANT
MUTANT
NACHR RECEPTOR
NACHR SUBTYPE
NM
NICOTINIC ACETYLCHOLINE RECEPTOR
NICOTINIC ACETYLCHOLINE RECEPTOR
NON-DESENSITIZING PHASE
NON-LINEAR CURVE FITTING
NON-RESPONSIVE
ORIENTATION RESULT
PENTAMERIC RECEPTOR
PMOLES/MG PROTEIN
PMOLES/MG PROTEIN
POSITIVE CHANGE
PROTEIN
PROTEIN
PUTATIVE BINDING LOOP
PUTATIVE BINDING SITE LOOP
PUTATIVE TURN REGION
PUTATIVE Β-STRAND
RAPID PERFUSION SYSTEM
RAPID RISE TIME
RAT ΕP121
RATE CONSTANT
RATE CONSTANT
REAGENT
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR BINDING STUDY
RECEPTOR CONFORMATION
RECEPTOR EXPRESSION
RECEPTOR FAMILY
RECEPTOR FUNCTION
RECEPTOR SUBTYPE
RECEPTOR SUBTYPE
RECEPTOR SUBTYPE
RECEPTOR SUBUNIT
RECEPTOR Γ-SUBUNIT
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
INCLUDING GABA RECEPTOR
RECORDING PROCEDURE
RELATIONSHIP
RELATIVE POSITION
REPRESENTATIVE MEMBER
RESIDUE-TURN
RESPONSE ELICITED
RESULTING EFFECT
INDIVIDUAL MUTATION RESULTING EFFECT
RISE TIME
RISE TIME
ROOM TEMPERATURE
S PERFUSION TIME
SECONDARY STRUCTURE
SELECTIVE LIGAND
SELECTIVE LIGAND
SEROTONIN
SEROTONIN TYPE
SERUM
STABILIZATION
STRUCTURAL CLASS
STRUCTURAL CLASS
STRUCTURAL CLASS
STRUCTURAL CLASS
STRUCTURAL CLASS
STRUCTURAL CLASS
LIGAND STRUCTURAL CLASS
LIGAND STRUCTURAL CLASS
STRUCTURAL DETAIL
STRUCTURAL FEATURE
STRUCTURAL HOMOLOGY
STRUCTURAL PERTURBATION
STRUCTURAL SIMILARITY
STRUCTURAL SIMILARITY
STRUCTURES REPRESENTATIVE
SUBUNIT
SUBUNIT
SUBUNIT
SUBUNIT
SUBUNIT
TC
TC
TC
TC
TC
TC
TC
TC
TC
TC
TC
TC
TC
TC
TC
TC
TC
TC
TC INHIBITION
TERTIARY STRUCTURE
RECEPTOR TERTIARY STRUCTURE
TEST COMPOUND
TEST COMPOUND
TORPEDO NACHR
TSA201 CELL
TUBOCURARINE
TYROSINE MUTATION
TYROSINE RESIDUE
TYROSINE RESIDUE
UNITS/ML PENICILLIN/STREPTOMYCIN
UNITS/ML PENICILLIN/STREPTOMYCIN
UNITS/ML PENICILLIN/STREPTOMYCIN
WILDTYPE
WILDTYPE RECEPTOR
WT RECEPTOR
WT RECEPTOR
WT RESPONSE
ΓL109
ΓL109
ΓL109
ΓL119
ΓL119
ΓN107
ΓS111
ΓS115
ΓY111
ΓY111
TORPEDO NACHR ΓY111
ΓY117
ΓY117
ΔR113
ΔT119
ΕP121
ΜM
ΜG
CDNA ΜG
ΜL
ΜL
SUPERFECT REAGENT ΜL
NICOTINIC ACETYLCHOLINE         RECEPTOR
NACHR
amplifier
B MAX
max
SEQUENCE HOMOLOGY
CHANGE
MUTAGENESIS
DESENSITIZATION
D VALUE
inhibition
CHANGE
MUTAGENESIS
antagonists
antagonists
SEQUENCE HOMOLOGY
DIEGO CA
SUPERFECT
SUPERFECT
TRANSFECTION
SUPERFECT
TUBOCURARINE
inhibition
AFFINITY
AFFINITY
FLUMAZENIL
applications
binding domains
responses
mutations
β-sheet
INTERACTION
DNA SEQUENCING
DNA
antagonists
SIDE
CONCENTRATION
CHANGE
CHANGE
GLYCINE
EXTRACELLULAR SOLUTION FLOW
SOLUTION FLOW
glycine residue
steps
SUBSTITUTION
MUTAGENESIS
AGONIST
examples
construction
solution
EXTRACELLULAR SOLUTION FLOW
EXTRACELLULAR SOLUTION
HOMOLOGOUS
RECEPTOR
ACHBP
GABA
W183
K
ALANINE MUTATION
binding domains
INTERACTION
CPBG
CPBG
CPBG
CPBG
CPBG
CPBG
CPBG
CPBG
CPBG
activation
mixtures
BASIS
RULER
LERISETRON
RECEPTOR
acetylcholine receptor
acetylcholine receptor
orientation
results
CHANGE
PERFUSION SYSTEM
RAPID RISE
ΕP121
RECEPTOR
expressions
RECEPTOR
functions
RECEPTOR
subtype
RECEPTOR
subtype
RECEPTOR
RECEPTOR
RECEPTOR
representatives
responses
rises
rises
PERFUSION TIME
classes
classes
homology
perturbations
similarities
similarities
representatives
TC
inhibition
tests
tests
NACHR
TSA201
tyrosine
tyrosine
tyrosine
penicillin/streptomycin
penicillin/streptomycin
penicillin/streptomycin
